SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001072613-16-000773
Filing Date
2016-04-29
Accepted
2016-04-29 16:54:57
Documents
1
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP II, L.P.VENBIO GLOBAL STRATEGIC GP II, LTD.

Document Format Files

Seq Description Document Type Size
1 sch13g_17939.htm SC 13G 164734
  Complete submission text file 0001072613-16-000773.txt   166375
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund II L.P. (Filed by) CIK: 0001634632 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89113 | Film No.: 161607718
SIC: 2834 Pharmaceutical Preparations